Societe Generale analyst Delphine Le Louet downgrades Alcon (NYSE:ALC) from Buy to Hold.
Why Baudax Bio Shares Are Trading Higher Today
Baudax Bio Inc (NASDAQ:BXRX) announced results from the second preplanned interim analysis of its Phase 2 trial of BX1000 for neuromuscular…